NRSN
Neurosense TherapeuticsFNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
NRSN vs peer average
26/100
NRSN vs. peer average (F vs. C)
Grade spread
A 1 · C 2 · D 4 · F 1
Graded peers loaded
Coverage
8 graded
100% of tracked
Peer overview
MDCX is the first available peer comparator.
Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $16.43M
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
NRSN
Neurosense Therapeutics
MDCX
Medicus
Grade
F
A
Momentum
11
11
Value
46
41
Sentiment
-
99
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Constructive
Grade position vs MDCX
NRSN / MDCX
Grade Position
Below peers
NRSN vs. peer average (F vs. C)
26/100
Momentum
11
NRSNValue
46
NRSNSentiment
-
-Rotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs NRSN
MDCX is the first peer returned for this comparison set.

